Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B. Riley Securities Maintains Buy on Arrowhead Pharma, Lowers Price Target to $55

B. Riley Securities analyst Mayank Mamtani maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and lowers the price target from $59 to $55.

byBenzinga Newsdesk

February 8, 2023

1 minute read

B. Riley Securities analyst Mayank Mamtani maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and lowers the price target from $59 to $55.

SailPoint Sees Q3 Adj. EPS $(0.07)-$(0.06) vs $(0.03), Sales $102M-$104M vs $103.69M Est.l Sees FY21 Adj. EPS (0.08)-$(0.04) vs $(0.10) Est., Sales $408M-$412M vs $409.15M Est.

By Bill Haddad

August 9, 5:55 PM

Financial Outlook: For the third quarter of 2021, SailPoint expects: Total ARR in the range of $315.0 million to $317.0 million Revenue in the range of $102.0 million to $104.0 million Non-GAAP loss from operations

SAIL

Why Ford Stock Is Falling

By Henry Khederian

February 3, 9:54 AM

Ford Motor Company (NYSE: F) shares are trading lower by 7.26% to $13.28 Friday morning after the company reported worse-than-expected fourth-quarter adjusted EPS results.